Open Targets
Aggregates public data to help scientists identify and prioritize drug targets for research.
| What is it | Aggregates public data to help scientists identify and prioritize drug targets for research. |
|---|---|
| Pricing | Unknown |
| Platform | Web Application |
| API | Yes |
| Works with | Claude AI |
| Best for | identifying therapeutic drug targets, prioritizing targets for drug development |
| Domain registered | 2016 |
Data updated Aug. 1, 2026
What does Open Targets do?
Open Targets is a pre-competitive consortium and open-source platform that helps scientists systematically identify and prioritize drug targets for therapeutic development. It aggregates data from multiple public sources—including genomics, genetics, clinical trials, and literature—to connect potential drug targets to diseases. The platform is freely available and designed to evaluate the strength of evidence linking a target to a disease, making it easier for researchers to decide which targets to pursue further.
The platform works by integrating diverse datasets into a unified, searchable interface. Users can look up a target (like a gene or protein) or a disease and see all supporting evidence, such as genetic associations, expression data, known drugs, and pathway information. Open Targets also provides computational tools like VIDRA (Variant-Informed Dose-Response Analysis) for modeling genetic dose-response relationships. What sets it apart is its commitment to open science: all data, methods, and results are made publicly available as soon as possible. The consortium includes partners from major pharmaceutical companies (GSK, Pfizer, Sanofi, MSD, Genentech) and research institutes (EMBL-EBI, Wellcome Sanger Institute), ensuring the work is both rigorous and relevant to real-world drug discovery.
Open Targets is most useful for drug discovery researchers in academia and industry, as well as bioinformaticians who need a comprehensive, up-to-date resource for target validation. It is also valuable for scientists studying disease mechanisms or looking for new therapeutic angles. By lowering the barrier to high-quality integrated data, Open Targets accelerates the early stages of drug development and promotes collaboration across the field.
Key features
What makes it stand outWho is Open Targets for?
Who benefits most from this toolTrust & presence
Similar tools
AI-powered drug discovery platform that accelerates pharmaceutical research and development
AI-powered research platform for scientists — search PubMed, ClinicalTrials.gov, and more to visualize connections between genes, drugs, and diseases.
AI drug discovery platform for target identification, molecule design, and clinical trial prediction
Vector + graph database platform for multimodal AI data, powering GenAI pipelines and intelligent agents
AI-powered protein design platform — generate optimized protein candidates and improve properties using your experimental data.
AI platform for pharmaceutical companies to de-risk drug development and predict clinical trial success.
AI-powered drug discovery platform that designs antibodies and medicines using generative AI and patient-relevant testing
AI-powered platform for biopharma companies to discover drug targets and optimize clinical trials using immune system data.
Works with Claude AI
View all →AI research and product company building safe, capable assistants like Claude
AI-powered project management hub — manage tasks, documents, and collaboration with built-in AI assistants.
AI-powered customer messaging platform with live chat, chatbots, and omnichannel support for businesses.
AI-powered enterprise work management platform that automates tasks, provides insights, and coordinates teams.
All-in-one marketing platform with AI — send emails, SMS, automate campaigns, and manage customer relationships in one place.
AI presentation maker and website builder — turn ideas into polished decks, docs, and sites in minutes
AI meeting assistant that transcribes conversations, generates summaries, and tracks action items automatically
Enterprise data integration and analytics platform — unify data sources, ensure quality, and build AI-powered dashboards.